Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

DIRECTOR DEALINGS SUMMARY: Biffa Municipal MD Sells 154,000 Shares

Tue, 04th Feb 2020 13:26

(Alliance News) - The follow is a round-up of share dealings by UK company directors and managers announced on Tuesday and not separately reported by Alliance News:

----------

Quarto Group Inc - CEO Chuk Kin Lau and associates buy 9.4 million shares total at GBP0.68 as part of publisher's GBP13.9 million open offer. Now holds 16.3 million shares, 39.8% of total.

----------

Biffa PLC - Roger Edwards, managing director for Municipal, sells 154,000 shares at GBP2.83, worth GBP435,820, on Friday last week.

----------

Jangada Mines PLC - Executive Chair Brian McMaster and Non-Executive Director Luis Azevedo each purchase 1.4 million shares at 1.8p, together worth GBP50,400, on Monday. McMaster now holds 55.2 million shares, 23.3%, while Azevedo has 54.1 million, 22.8%.

----------

Bonhill Group PLC - Chief Executive Simon Stilwell buys 145,000 shares at 28p, worth GBP40,600, on Tuesday. Now holds 865,500 shares, 1.8% of total.

----------

Vietnam Holding Ltd - Craig Martin, chair of investment manager Dynam Capital Ltd, buys 10,000 shares at 172 pence, worth GBP17,200, on Monday. Now holds 100,000 shares, 0.2% of total.

----------

Tiziana Life Science PLC - Executive Chair Gabriele Cerrone buys 5,000 American depositary shares, each representing 5 Tiziana shares, at USD2.37 per ADS, on Monday. The purchase was worth USD11,850. Cerrone now holds 64.3 million shares, 47% of the total.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Apr 2020 09:43

Tiziana Life Sciences files for patent on potential Covid-19 therapy

(Sharecast News) - Biotechnology company Tiziana Life Sciences has filed a provisional patent application on the combination of nanoparticle-Actinomycin D (NP-ACT D) with anti-interleukin-6 receptor monoclonal antibody (anti-IL-6R), it announced on Monday, as a potential therapy for the management of Covid-19 disease.

Read more
24 Apr 2020 18:39

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Tiziana Life Sciences Acquires Potential Covid-19 Treatment Medication

Read more
9 Apr 2020 11:23

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

UK WINNERS & LOSERS SUMMARY: Lockdowns Lift Just Eat Takeaway Orders

Read more
9 Apr 2020 09:12

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Tiziana Life Sciences Shares Double On Covid-19 Treatment News

Read more
9 Apr 2020 08:03

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

LONDON BRIEFING: Bank Of England Extends UK Government's Overdraft

Read more
16 Mar 2020 17:48

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Tiziana Raises USD10 Million To Help Fund Covid-19 Drug Development

Read more
12 Mar 2020 14:31

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Tiziana Secures USD10 Million To Help Coronavirus Antibody Development

Read more
11 Mar 2020 12:15

Tiziana Life Sciences expediting development of Covid-19 drug

(Sharecast News) - Tiziana Life Sciences said on Wednesday that it is expediting the development of a drug that could help in the treatment of people infected with Covid-19.

Read more
11 Mar 2020 10:51

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Tiziana Shares Skyrocket On Expedited Covid-19 Treatment Development

Read more
17 Feb 2020 14:30

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Tiziana Life Sciences Proposes ADS Offering On Nasdaq

Read more
21 Jan 2020 16:09

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Tiziana Life Sciences Hires OKYO Pharma Director MacRae As Non-Exec

Read more
14 Jan 2020 14:42

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

DIRECTOR DEALINGS: Tiziana Life Says Associate Of Chair Bought Shares

Read more
13 Jan 2020 11:07

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Tiziana Life Science To Cancel AIM Trading Ahead Of Move To Bermuda

Read more
9 Jan 2020 12:21

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Tiziana Says Antibody Foralumab "Well Tolerated" At All Doses Tested

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.